SeekingAlpha · Sep 14, 2026
MS
AMEX · MSOS
AdvisorShares Pure US Cannabis ETF
Financial Services · Asset Management
$4.92
Down-$0.01 (-0.20%)
Updated Sep 17, 2026, 7:54 AM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 663.64M
- P/E ratio
- —
- Dividend yield
- 0.00%
- 52-week range
- $3.08 – $5.97
- Volume
- 2.12M
- Avg. volume
- 9.48M
Price performance
MSOS price history
1M range · 20 trading sessions · Daily adjusted prices
MSOS closed at $4.92 after 20 trading sessions, up 3.36% for the selected period.
- Last close
- $4.92
- Period change
- +3.36%
- Period low
- $4.74
- Period high
- $5.11
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $4.945 | $4.99 | $4.84 | $4.92 | 2.12M |
| Sep 15, 2026 | $4.93 | $4.995 | $4.8301 | $4.93 | 3.23M |
| Sep 14, 2026 | $4.75 | $5.055 | $4.68 | $4.92 | 5.52M |
| Sep 11, 2026 | $4.87 | $4.96 | $4.75 | $4.75 | 4.61M |
| Sep 10, 2026 | $5.00 | $5.075 | $4.82 | $4.83 | 5.22M |
| Sep 9, 2026 | $5.08 | $5.195 | $4.965 | $5.05 | 3.73M |
| Sep 8, 2026 | $5.07 | $5.24 | $4.96 | $5.11 | 4.61M |
| Sep 4, 2026 | $4.95 | $5.11 | $4.88 | $5.11 | 4.19M |
| Sep 3, 2026 | $4.95 | $5.04 | $4.895 | $4.95 | 3.52M |
| Sep 2, 2026 | $4.90 | $5.11 | $4.89 | $4.97 | 4.68M |
| Sep 1, 2026 | $4.94 | $5.063 | $4.86 | $4.93 | 3.64M |
| Aug 31, 2026 | $5.02 | $5.06 | $4.88 | $4.95 | 3.92M |
| Aug 28, 2026 | $4.81 | $5.08 | $4.75 | $4.99 | 8.9M |
| Aug 27, 2026 | $4.88 | $4.925 | $4.765 | $4.83 | 3.47M |
| Aug 26, 2026 | $4.89 | $5.07 | $4.85 | $4.85 | 5.52M |
| Aug 25, 2026 | $4.90 | $4.97 | $4.84 | $4.92 | 3.9M |
| Aug 24, 2026 | $4.91 | $4.975 | $4.79 | $4.89 | 3.34M |
| Aug 21, 2026 | $4.76 | $4.98 | $4.72 | $4.96 | 6.38M |
| Aug 20, 2026 | $4.75 | $4.77 | $4.65 | $4.74 | 1.95M |
| Aug 19, 2026 | $4.55 | $4.84 | $4.51 | $4.76 | 6.9M |
Latest MSOS news
The latest Smart Investors Daily articles mentioning MSOS.
Stock researchCompany · Overview
MSOS research
Overview
Company profile and research snapshot.
Company profile
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
SeekingAlpha · Jul 9, 2026
MSOS: Broader 280E Relief Could Add Meaningful Upside, But The Risk-Reward Suggests A Hold
MSOS ETF outlook: high volatility and cannabis rescheduling uncertainty. Top-heavy holdings face 280E risk; DEA hearing is key. Learn more about the MSOS ETF here.
SeekingAlpha · Jul 9, 2026
MSOS: Adult-Use Rescheduling The Next Catalyst For Cannabis Stocks
The AdvisorShares Pure US Cannabis ETF is rated a buy, driven by real regulatory progress and potential further catalysts. Click here to read more on MSOS.
Yahoo · Jun 18, 2026
Cannabis Stocks Pop As Another U.S. Company Applies to List on NYSE
Cannabis companies are racing the clock to list on the NYSE, as Glass House applies. A DEA hearing beginning on June 29 could catalyze the next Green Rush.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
